Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " December 23, 2009":" January 22, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 23, 2009":" January 22, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Condition: HIV Infections
Intervention: Drug: ibalizumab
2 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
3 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
4 Completed Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
5 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
6 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
7 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
8 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
9 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
10 Unknown  Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: First-line Antiretroviral Therapy
11 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
12 Completed Observational Study of Blood Treated With Cytolin
Condition: HIV Infections
Intervention:
13 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
14 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir
15 Completed Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Echinacea
16 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
17 Completed Telephone Based Cognitive Behavioral Therapy for HIV Related Depression
Conditions: Depression;   HIV Infections
Interventions: Behavioral: Telephone-based CBT;   Behavioral: Enhanced Usual Care
18 Completed Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Conditions: Healthy;   HIV Infections
Interventions: Drug: Digoxin;   Drug: Maraviroc
19 Completed High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
20 Completed Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: Cotrimoxazole prophylaxis;   Drug: SP IPT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.